Metraipolis › archive › dc_a03f2c142bbd

Real-world effectiveness of Paxlovid in protecting Long COVID for outpatient adult patients: A target trial emulation study from the RECOVER Initiative — Europe PMC PMID:42949887

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42949887
DOI: 10.1371/journal.pgph.0005771
License (as archived): solo-consultazione
Archived: 2026-10-31T21:26:11.704Z
SHA-256 of the archived text: 216ce30f445805a635e02f869e7d8bbd15dd793335232974f214f5c0049aa074
Stable URL of this page: https://metraipolis.com/documento/dc_a03f2c142bbd

How to cite

Real-world effectiveness of Paxlovid in protecting Long COVID for outpatient adult patients: A target trial emulation study from the RECOVER Initiative — Europe PMC PMID:42949887 — Europe PMC (en), https://europepmc.org/article/MED/42949887 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a03f2c142bbd (Metraipolis archive dc_a03f2c142bbd, sha256 216ce30f445805a635e02f869e7d8bbd15dd793335232974f214f5c0049aa074)

BibTeX

@misc{dca03f2c142bbd,
  title = {Real-world effectiveness of Paxlovid in protecting Long COVID for outpatient adult patients: A target trial emulation study from the RECOVER Initiative — Europe PMC PMID:42949887},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42949887},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a03f2c142bbd; sha256 216ce30f445805a635e02f869e7d8bbd15dd793335232974f214f5c0049aa074},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42949887. Agents can read the archived copy with the MCP tool read_document.